Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Eli
FDA Approves ZEPBOUND — Eli Lilly and Company

Eli Lilly’s ZEPBOUND (tirzepatide) has received FDA approval to treat adults with diabetes mellitus type 2, significantly expanding the company’s domi...

Zydus
FDA Approves SITAGLIPTIN AND METFORMIN HYDROCHLORIDE — Zydus Lifesciences Limited

Zydus Lifesciences Limited received FDA approval for its combination tablet of sitagliptin and metformin hydrochloride, a move aimed at broadening acc...

Nuvaila
FDA Approves WEZLANA — Nuvaila Limited

Nuvaila Limited announced the 2023 FDA approval of WEZLANA, an intravenous ustekekinumab-auub, positioning the manufacturer to leverage significant ma...

NorthStar
FDA Approves OXCARBAZEPINE — NorthStar RxLLC

NorthStar RxLLC announced on October 20, 2023, that the FDA has granted approval for its Oxcarbazepine tablet, ANDA 216749, offering a potential high-...

UCB,
FDA Approves ZILBRYSQ — UCB, Inc.

UCB, Inc. announced on Thursday that the FDA granted accelerated approval to its novel antiphospholipid syndrome drug ZILBRYSQ (zilucoplan), signaling...

Novartis
FDA Approves COSENTYX — Novartis Pharmaceuticals Corporation

# FDA Approves Novartis's Cosentyx (Secukinumab) Intravenous Formulation Novartis Pharmaceuticals Corporation received FDA approval for an intravenou...

Laurus
FDA Approves METFORMIN HYDROCHLORIDE — Laurus Labs Limited

Laurus Labs Limited received FDA approval on October 5, 2023, for its generic product under application number ANDA217631, signaling a significant exp...

MARKSANS
FDA Approves ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES, 20 MG — MARKSANS PHARMA LIMITED

On September 29, Marksans Pharma Limited received approval from the FDA for its ANDA217264 to market Esomeprazole Magnesium Delayed-Release Capsules, ...

Pfizer
FDA Approves BOSULIF — Pfizer Laboratories Div Pfizer Inc

Pfizer secured the FDA's approval of BOSULIF (bosutinib) on September 26, a regulatory win expected to bolster the pharmaceutical giant's oncology rev...

Oyster
FDA Approves RYZUMVI — Oyster Point Pharma, Inc.

On September 25, Oyster Point Pharma announced FDA approval of RYZUMVI (phentolamine mesylate) ophthalmic solution for the treatment of surgically ind...

GlaxoSmithKline
FDA Approves OJJAARA — GlaxoSmithKline LLC

GlaxoSmithKline plc has secured regulatory approval from the FDA for Momelotinib Dihydrochloride Monohydrate (NDA216873), a novel oral therapy aiming ...

Gamida
FDA Approves APHEXDA — Gamida Cell Inc.

# FDA Approves Gamida Cell's APHEXDA for Hematopoietic Stem Cell Mobilization Gamida Cell Inc. received FDA approval for APHEXDA (motixafortide aceta...

Fresenius
FDA Approves GADOBUTROL — Fresenius Kabi USA, LLC

# FDA Approves Fresenius Kabi's Generic Gadobutrol, Expanding MRI Contrast Agent Competition Fresenius Kabi USA, LLC has received FDA approval for it...

Heritage
FDA Approves MYCOPHENOLATE MOFETIL — Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

# FDA Approves Heritage Pharmaceuticals' Generic Mycophenolate Mofetil Heritage Pharmaceuticals Inc. (operating as Avet Pharmaceuticals Inc.) has rec...

Camber
FDA Approves LISDEXAMFETAMINE DIMESYLATE — Camber Pharmaceuticals, Inc.

# FDA Approves Generic Version of Lisdexamfetamine Dimesylate Camber Pharmaceuticals, Inc. received FDA approval for its generic formulation of lisde...

Alembic
FDA Approves BRIMONIDINE TARTRATE AND TIMOLOL MALEATE — Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited secured FDA approval for its generic Brimonidine Tartrate and Timolol Maleate ophthalmic solution, allowing the compan...

Camber
FDA Approves LISDEXAMFETAMINE DIMESYLATE — Camber Pharmaceuticals, Inc.

Camber Pharmaceuticals, Inc. announced the approval of its Abbreviated New Drug Application for lisdexamphetamine dimesylate, a strategic development ...

Solco
FDA Approves LISDEXAMFETAMINE DIMESYLATE — Solco Healthcare US,LLC

Solco Healthcare US, LLC has received FDA approval for the oral lisdexamphetamine dimesylate capsules (ANDA 216266), paving the way for the anticipate...

Lannett
FDA Approves LISDEXAMFETAMINE DIMESYLATE — Lannett Company, LLC

Lannett Company announced the FDA approval of its lisdexexamfetamine dimesylate generic this week, with market analysts suggesting the move will deepe...

Steriscience
FDA Approves FOCINVEZ — Steriscience Specialties Private Limited

# FDA Approves Steriscience Specialties' FOCINVEZ, Expanding IV Antiemetic Options in Competitive Market Steriscience Specialties Private Limited rec...